Russell Steven Jon, CMO, reported a transaction classified as grant at Beta Bionics, Inc. involving 90637.000000 shares for an estimated $0.00. Reported holdings after the transaction were 90637.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Medical Officer
One-fourth of the shares subject to this option shall vest one year after November 14, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.
0 other filings
0 recent txs